New Pharma Clusters To Come Up In Nine Telangana Districts

Hyderabad: Shelving the previous BRS regime’s single mega pharma city plan, the state government has now decided to set up a dozen smaller pharma villages across the state – at least 50 to 60 km beyond the Outer Ring Road (ORR). The nine districts identified for these clusters are: Rangareddy, Sangareddy, Vikarabad, Mahabubnagar, Medak, Medchal-Malkajgiri, Siddipet, Yadadri-Bhuvanagiri and Nalgonda.

Already, collectors of these districts have been asked to identify land parcels – of 1,000 to 3,000 acres — to execute the project, expected to take off in the next 12 months. It is being conceived as part of the state government’s ‘Mega Master Plan – 2050’.

Salient features of these pharma villages: Limited footprint of not more than 20 to 30 companies at each site, located far from human habitation and closer to the proposed Regional Ring Road (RRR), and self-sustaining.

“The idea is to develop 10 to 12 such villages that are well connected – through the RRR and state/national highways – and self-contained with education, health and social infrastructure,” said Jayesh Ranjan, principal secretary, IT and industries.

Skilling facilities being planned to train & employ locals: Jayesh

Housing is also an important factor that we are considering here, having learnt our lesson with Genome Valley where the lack of residential space around it was a constant complaint,” said Jayesh Ranjan.

Explaining why the government has decided to restrict the footprint in each village he said: “A smaller group of companies will help with better monitoring and regulating issues such as pollution. Even the accountability quotient of these firms will be higher. In case of a larger pool, it is tough to track every operation,” said Ranjan, adding there is also a plan to set up skilling facilities in these clusters to train and employ local talent.

Industry experts believe it is a model worth experimenting with. “It is a myth that industries have to be close to the city to succeed. The advantage with Telangana is that almost every part of it is just a few hours’ drive from the Shamshabad airport and that augurs well for investors. Smaller clusters will be ecologically friendly, sustainable, and also be a great way to create employment opportunities,” said Vishal Goel, co-founder of JV Ventures.

While urban planners and environmentalists agree that decentralising economic activity is the future, they aren’t convinced about this plan addressing issues like pollution. “Telangana is already saturated with pharma activity. We have seen models where even single pharma units – in areas like Chotuppal, Polepally, Pochampally etc – had a damaging impact on the environment,” said environmentalist D Narasimha Reddy.

Architect Srinivas Murthy averred: “Cleaning a city requires multiple solutions including strengthening public transport and capping construction activity.

Related Posts

  • Pharma
  • July 16, 2025
  • 136 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

  • Pharma
  • July 16, 2025
  • 45 views
Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

The pharma sector will be in focus on July 16, after Donald Trump said that pharmaceuticals tariffs would be implemented soon. Shares of pharmaceutical companies traded flat on Wednesday, July…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Famous Vaidyaratnam Ayurveda Clinic in Delhi is now more Accessible to Patients

Famous Vaidyaratnam  Ayurveda  Clinic in Delhi is now more Accessible to Patients